Europe Poloxamer Market Size & Outlook, 2026-2034

Europe Poloxamer Market Insights

Based on Reed Intelligence findings, the Europe Poloxamer Market size reached USD 310.8 Million in 2025 and is expected to grow to USD 700.33 Million by 2034.
During 2026–2034, the market is forecasted to advance at a CAGR of 9.39%.
Poloxamer 188 represented the largest share of the Type market in terms of size in 2025.
Among the Type segments, Poloxamer 407 is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings

In 2025, Europe accounted for 26.34% of the global Poloxamer Market size.
By 2034, United States is projected to lead the global market in terms of market size.
Italy is projected to emerge as the fastest-growing market in Europe, reaching USD 73.85 Million by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 310.8 Million
Market Size In 2034	USD 700.33 Million
Largest segment	Poloxamer 188
Units	Revenue in USD Million
CAGR	9.39% (2026-2034)
Segmnetation Covered
Europe	Germany United Kingdom France Italy Spain Russia Nordic Benelux
Type	Poloxamer 188 Poloxamer 407 Poloxamer 338 Other Types
Application	Pharmaceutical Formulations Drug Delivery Systems Personal Care and Cosmetics Industrial Cleaning Biotechnology Applications
End Use	Pharmaceutical Companies Biotechnology Companies Research Laboratories Cosmetic Manufacturers Contract Manufacturing Organizations
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Europe Poloxamer Market Country 2026-2034 (USD Million)

Europe	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Germany	XX.x	XX.x	XX.x	77.83	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
United Kingdom	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
France	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Italy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Spain	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Russia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nordic	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Benelux	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Europe Poloxamer Market Type 2026-2034 (USD Million)

Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Poloxamer 188	XX.x	XX.x	XX.x	154.19	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Poloxamer 407	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Poloxamer 338	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Other Types	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Europe Poloxamer Market Application 2026-2034 (USD Million)

Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pharmaceutical Formulations	XX.x	XX.x	XX.x	131.26	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Drug Delivery Systems	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Personal Care and Cosmetics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Industrial Cleaning	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Biotechnology Applications	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Europe Poloxamer Market End Use 2026-2034 (USD Million)

End Use	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pharmaceutical Companies	XX.x	XX.x	XX.x	139.8	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Biotechnology Companies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research Laboratories	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cosmetic Manufacturers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Contract Manufacturing Organizations	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.